Company news

ABVC BioPharma, Inc. news in 2019

ABVC BioPharma, Inc.'s news releases, calls and decks from 2019, newest first.

View company

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

December 4, 2019

American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study

November 13, 2019